Suppr超能文献

氨基葡萄糖和软骨素的使用与 C-反应蛋白浓度的关系:按补充形式、配方和剂量的结果。

Glucosamine and Chondroitin Use in Relation to C-Reactive Protein Concentration: Results by Supplement Form, Formulation, and Dose.

机构信息

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, St. Louis, MO, USA.

出版信息

J Altern Complement Med. 2021 Feb;27(2):150-159. doi: 10.1089/acm.2020.0283. Epub 2020 Dec 7.

Abstract

Glucosamine and chondroitin supplements have been associated with reduced inflammation, as measured by C-reactive protein (CRP). It is unclear if associations vary by formulation (glucosamine alone vs. glucosamine+chondroitin), form (glucosamine hydrochloride vs. glucosamine sulfate), or dose. The authors evaluated these questions using cross-sectional data collected between 1999 and 2010 on 21,917 US adults, surveyed as part of the National Health and Nutrition Examination Survey (NHANES). Glucosamine and chondroitin use was assessed during an in-home interview; exposures include supplement formulation, form, and dose. CRP was measured using blood collected at interview. Survey-weighted linear regression was used to evaluate the multivariable-adjusted association between exposures and log-transformed CRP. In early years (1999-2004), use of glucosamine (ratio = 0.87; 95% confidence interval [CI] = 0.79-0.96) and chondroitin (ratio = 0.83; 95% CI = 0.72-0.95) was associated with reduced CRP. However, associations significantly varied by calendar time (-interaction = 0.04 and -interaction = 0.01, respectively), with associations nonsignificant in later years (ratio = 1.09; 95% CI = 0.94-1.28 and ratio = 1.16; 95% CI = 0.99-1.35, respectively). Consequently, all analyses have been stratified by calendar time. Associations did not significantly differ by formulation in either set of years; however, significant associations were observed for combined use of glucosamine+chondroitin (ratio = 0.82; 95% CI = 0.72-0.95; ratio = 1.16; 1.00-1.35), but not glucosamine alone. Associations also did not significantly differ by supplement form. Even so, a significant inverse association was observed only for glucosamine sulfate in the early years (ratio = 0.78; 95% CI = 0.64-0.95); no significant association was observed for glucosamine hydrochloride. No significant trends were observed by dose. Although a significant inverse association was observed for glucosamine and chondroitin and CRP in early years, this association did not hold in later years. This pattern held for combined use of glucosamine+chondroitin as well as glucosamine sulfate, although associations did not significantly vary by supplement form, formulation, or dose. Further study is needed to better understand these associations in the context of calendar time.

摘要

氨基葡萄糖和软骨素补充剂与 C 反应蛋白(CRP)测量的炎症减轻有关。目前尚不清楚这些关联是否因配方(单独氨基葡萄糖与氨基葡萄糖+软骨素)、形式(盐酸氨基葡萄糖与硫酸氨基葡萄糖)或剂量而异。作者使用 1999 年至 2010 年期间在全美健康和营养检查调查(NHANES)中对 21917 名美国成年人进行的横断面数据评估了这些问题。在家庭访谈中评估了氨基葡萄糖和软骨素的使用情况;暴露包括补充剂配方、形式和剂量。使用访谈时采集的血液测量 CRP。使用调查加权线性回归评估暴露与对数转换 CRP 之间的多变量调整关联。在早期(1999-2004 年),使用氨基葡萄糖(比值=0.87;95%置信区间 [CI]=0.79-0.96)和软骨素(比值=0.83;95%CI=0.72-0.95)与 CRP 降低有关。然而,关联随时间显著变化(-交互作用=0.04 和 -交互作用=0.01),在后期关联不显著(比值=1.09;95%CI=0.94-1.28 和比值=1.16;95%CI=0.99-1.35)。因此,所有分析均按时间分层。在这两组年份中,配方之间的关联没有显著差异;然而,在联合使用氨基葡萄糖+软骨素时观察到显著关联(比值=0.82;95%CI=0.72-0.95;比值=1.16;1.00-1.35),但单独使用氨基葡萄糖时则没有关联。补充剂形式也没有显著差异。尽管如此,仅在早期观察到硫酸氨基葡萄糖与 CRP 呈显著负相关(比值=0.78;95%CI=0.64-0.95);盐酸氨基葡萄糖则没有显著关联。剂量没有观察到显著趋势。尽管在早期观察到氨基葡萄糖和软骨素与 CRP 呈显著负相关,但在后期这种关联并不成立。这种模式也适用于联合使用氨基葡萄糖+软骨素以及硫酸氨基葡萄糖,尽管补充剂形式、配方或剂量没有显著差异。需要进一步研究以更好地了解这些与时间相关的关联。

相似文献

引用本文的文献

本文引用的文献

6
Chondroitin for osteoarthritis.用于骨关节炎的软骨素。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD005614. doi: 10.1002/14651858.CD005614.pub2.
10
Specialty supplement use and biologic measures of oxidative stress and DNA damage.专业补充剂的使用与氧化应激和 DNA 损伤的生物标志物。
Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2312-22. doi: 10.1158/1055-9965.EPI-13-0470. Epub 2013 Aug 5.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验